Rituximab - Wikipedia, the free encyclopedia
Rituximab, sold under the trade names Rituxan and MabThera, is a chimeric monoclonal antibody against the protein CD20, which is primarily found on the surface of B cells.
Hairy cell leukemia - Wikipedia, the free encyclopedia
Rituximab has successfully induced a complete response in Hairy Cell-Variant. [32] Rituximab's major side effect is serum sickness, commonly described as an "allergic reaction ...
Hotline: May, 2006 - Abatacept and Rituximab
Hotline Abatacept and Rituximab . Two new biologic agents, abatacept (Orencia) and rituximab (Rituxan), have recently been approved for the treatment of rheumatoid arthritis.
HIGHLIGHTS OF PRESCRIBING INFORMATION
U.S. BL 103705/5297 Amendment: Rituximab Genentech, Inc. 1 of 31/Regional (RA): Rituxan Final HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the ...
Rituximab (Rituxan) in Lymphomas
Rituximab is a new form of treatment for Non-Hodgkin Lymphomas (NHL). It binds to special molecules on the surface of cancer cells and inactivates them. Read on to find out how ...
Rituximab
Drug details for Rituximab. ... Rituximab is available for intravenous (IV) use. How It Works. Rituximab belongs to a group of medicines known as monoclonal antibodies.
Rituximab Injection: MedlinePlus Drug Information
[Posted 09/11/2008] Genentech informed healthcare professionals of revisions to prescribing information for rituximab (Rituxan) regarding a case of progressive multifocal ...
arc :: Drug information: Rituximab
Rituximab (brand name MabThera) is a new type of drug which removes antibody-producing white blood cells called B-cells. Antibodies are proteins which are produced by the body in ...
Rituximab - Medpedia
Rituximab is a drug that suppresses the immune system. This drug is a genetically engineered antibody that functions like the antibodies that the body produces naturally. It was ...
Rheumatoid arthritis (refractory) - rituximab
The summary of the published technology appraisal on Rheumatoid arthritis (refractory) - rituximab. It links to the published guidance and key documents.
Rituximab Helps Patients with Recurrent Lymphomas - National Cancer ...
Two studies from Germany showed the targeted therapy rituximab (Rituxan®) to be effective in treating recurrent or refractory follicular and mantle cell lymphomas. Findings from ...